From what I understand, currently PIQ's (PromarkerD) revenue model works on the basis of royalties. Royalties are generated for every test conducted. I understand that the tests are offered out from our partners (e.g. Patia) branch of analytical laboratories.
So one could deduce that with the above model, the more connections our partners have, the more revenue for PIQ. Unfortunately this means that we have to rely on our partners to "offer out" the test to their connections for us to generate revenue (not necessarily a bad thing if our partners are able to offer out to a large market).
For significant revenue, I'm assuming we would need to partner up with an organisation that is well connected globally (that is, assuming the above revenue model is the one PIQ will retain).
Anyone else have another take on this? Any other ideas on how to "break" into the market?
From what I understand, currently PIQ's (PromarkerD) revenue...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.005(0.49%) |
Mkt cap ! $134.2M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.00 | $134.2K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3987 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |